Rincon Bio performs Huh7 xenograft models to test efficacy of preclinical therapies. Please see below for additional information or to request a quote.
Huh7 cells were derived from a 57 year old Japanese male with hepatocellular carcinoma
Oncogene: p53 mutation
Used in xenografts to test the efficacy of novel cancer therapeutics. Tumors develop after being injected into the flank of immunocompromised mice.
Rincon Bio Growth Curve
Cell Line: Huh-7
Mouse Strain: NOD.CB17 Prkd<Scid>/NCrHsd from Envigo
Positive Control: Sorafenib and Ozanimod
Concentration: Sorafenib 30mg/kg, Ozanimod 60mg/kg
Cells Implanted per Animal: 3 million
From implant to stratification: 32 days
Stratification Size: 115mm^3
Dosing: Daily oral dosing for 28 days
WHY WORK WITH
When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices
Most efficacy studies can be initiated within two business days.
We love our clients! We are flexible and easy to work with. And we take a personal interest in our clients' studies.